Skip lymph node metastasis in gastric cancer: is it skipping or skipped?
Open Access
- 24 February 2015
- journal article
- Published by Springer Science and Business Media LLC in Gastric Cancer
- Vol. 19 (1), 206-215
- https://doi.org/10.1007/s10120-015-0472-5
Abstract
Skip metastasis is the presence of a metastatic lymph node (LN) in an extraperigastric (EP) area without perigastric (PG) involvement. The mechanism and prognosis of skip metastasis are still unknown. The purpose of this study was to scrutinize the clinical significance of skip metastasis in gastric cancer. Data were reviewed from 6,025 patients who had undergone gastrectomy for primary gastric cancer. Patients were categorized as a PG-only group when the metastatic LNs were limited to only the PG area, as a PG + EP group if metastatic LNs extended to both the PG area and the EP area, and as a skip group if metastatic LNs were in the EP area but there were no metastatic LNs in the PG area. After we had performed matching, the prognosis of the skip group was worse than that of the PG-only group (adjusted hazard ratio 1.69, 95 % confidence interval 1.13–2.54) and was similar to that of the PG + EP group (adjusted hazard ratio: 1.54, 95 % confidence interval 0.92–2.59). The number of retrieved LNs was less in the skip group than in the other groups, especially from the PG area (p The prognosis of the skip group was worse than that of the PG-only group and was similar to that of the PG + EP group when the tumor stage was considered. It is difficult to conclude whether skip metastasis is real skipping of cancer cells or a result of inadequate LN sampling. Further evaluation of LNs in the PG area of the skip group could provide more clues for the mechanism of skip metastasis.Keywords
This publication has 33 references indexed in Scilit:
- Sialyl Lewis X as a predictor of skip N2 metastasis in clinical stage IA non-small cell lung cancerWorld Journal of Surgical Oncology, 2013
- A novel insight of sentinel lymph node concept based on 1-3 positive nodes in patients with pT1-2 gastric cancerBMC Cancer, 2011
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals Of Oncology, 2010
- Sentinel Node Mapping and Skip Metastases in Patients with Early Gastric CancerAnnals of Surgical Oncology, 2009
- Validity of modified gastrectomy combined with sentinel node navigation surgery for early gastric cancerGastric Cancer, 2007
- Clinical significance of skip metastasis in patients with gastric cancerGastric Cancer, 2007
- Impact of skip metastasis in gastric cancerAnz Journal of Surgery, 2005
- Mapping sentinel nodes in patients with early-stage gastric carcinomaBritish Journal of Surgery, 2003
- Clinicopathological analysis of early gastric cancer with solitary lymph node metastasisBritish Journal of Surgery, 2002
- Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancerGastric Cancer, 1999